A Maple Grove, Minn., company has launched a new long-term hemodialysis catheter with a coating it says will decrease thrombus accumulation.
Uroplasty, Inc., based in Minnetonka, Minn., has introduced a newly designed endoscopic injection needle that can be used in conjunction with the system used to inject Macroplastique.
The FDA is reviewing Abbott’s supplemental New Drug Application for a new six-month 45-mg formulation of Lupron Depot (leuprolide acetate for depot suspension) for the palliative treatment of advanced prostate cancer.
Watson Pharmaceuticals has received FDA approval of Trelstar (triptorelin pamoate for injectable suspension) 22.5 mg, the first and only six-month intramuscular gonadotropin releasing hormone (GnRH) agonist for the palliative treatment of advanced prostate cancer.
A new injection device for the endoscopic treatment of vesicoureteral reflux (VUR) is designed to give urologists greater control and precision in VUR repair, according to the device’s maker, Cook Medical, of Bloomington, Ind.
SAN FRANCISCO—Active surveillance of small renal masses (SRMs) may be an appropriate approach for many patients, especially older individuals and those with comorbidities that would complicate treatment or reduce life expectancy, according to Michael Jewett, MD, of Princess Margaret Hospital and the University of Toronto.
An apology or explanation can be priceless to the loved one of someone who died during surgery, but many physicians are afraid that any condolences or expressions of sympathy or regret will end up being costly to them in the event of a malpractice lawsuit.